Hong Melina, Warum Daniel, Karamanian Ara
Saba University School of Medicine, Saba, Netherland-Antilles.
J Radiol Case Rep. 2013 Feb 1;7(2):1-10. doi: 10.3941/jrcr.v7i2.1210. Print 2013 Feb.
Intramural esophageal hematoma is part of a spectrum of esophageal injuries. Vomiting and straining, endoscopic procedures and bleeding disorders are the most common predisposing factors. However, it can also be an unusual complication of anticoagulation and/or thrombolysis therapy. The most common symptoms are retrosternal chest pain, dysphagia and hematemesis. Computed tomography is the modality of choice and treatment is medically conservative with the cessation of Warfarin and thrombolysis use. When anticoagulation and/or thrombolysis therapy is necessary, periodic reassessment for symptoms of intramural esophageal hematoma may be helpful for early identification and management. We described one case of intramural esophageal hematoma possibly resulting from anticoagulation and/or thrombolysis therapy in the setting of pulmonary embolism.
壁内食管血肿是食管损伤谱系的一部分。呕吐、用力、内镜操作和出血性疾病是最常见的诱发因素。然而,它也可能是抗凝和/或溶栓治疗的一种罕见并发症。最常见的症状是胸骨后胸痛、吞咽困难和呕血。计算机断层扫描是首选的检查方式,治疗以停用华法林和溶栓药物进行医学保守治疗。当有必要进行抗凝和/或溶栓治疗时,定期重新评估壁内食管血肿的症状可能有助于早期识别和处理。我们描述了一例可能由肺栓塞背景下的抗凝和/或溶栓治疗导致的壁内食管血肿病例。